The Firm is representing the Gray Foundation in connection with the foundation’s donation of $25 million in funding for seven multi-institutional research teams to study new approaches for the early detection, diagnosis and therapy of BRCA-related cancers. These grants are the culmination of a strategic model designed to best align funding with the most promising topics in the field. The multi-institutional, multi-disciplinary teams, some of which include international researchers, will receive up to $5 million each.
The Gray Foundation is focused on accelerating research, improving treatment and raising awareness for individuals who have inherited BRCA mutations.
The Simpson Thacher team includes Kevin Roe and Jennifer Obus (Exempt Organizations).